Stryker Corporation
Stryker Corporation is a medical technology company within the healthcare sector, headquartered in Portage. Established in 1941, the corporation operates through two primary divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures, such as hips and knees, as well…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
+0.5%
1W
+6.2%
1M
+3.5%
6M
-14.2%
YTD
-16.2%
1Y
-20.2%
2Y
-18.4%
5Y
+10.6%
10Y
+156.7%
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~22% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$310.00
CONSENSUS
US$365.89
MEDIAN
US$370.00
PRICE TARGET HIGH
US$420.00
1
STRONG BUY
36
BUY
15
HOLD
0
SELL
0
STRONG SELL
52
TOTAL · Buy
As of: 12/10/2026
P/E
30.28
P/B
4.71
EV/EBITDA
18.62
RETURN ON EQUITY
5.3%
NET MARGIN
19.4%
DEBT/EQUITY
0.62
DIVIDEND YIELD
1.2%
AS OF
30/06/2026
FREE FLOAT
90.8%
FLOAT SHARES
348,134,732
AVG. DAILY VOLUME (30D)
2,957,521
Wells Preston Wendell
Wells Preston Wendell
Wells Preston Wendell
BRAINERD MARY K
BRAINERD MARY K
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.5%
Forums (Reddit)
Stryker Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Kevin A. Lobo, the company employs around 56,000 people.
The IPO was on 17/03/1980; the stock trades on NYSE under the ticker SYK.
52 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$365.89, ranging from US$310.00 to US$420.00, with a median of US$370.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 22% stronger than usual.
Yes. The last dividend was US$0.88 per share, ex-date 30/09/2026, paid on 30/10/2026.
The dividend yield is 1.2% (as of 30/06/2026).
Comparable stocks include Abbott Laboratories, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings, Align Technology and Bio-Rad Laboratories.
Clicking "Analyze stock" lets five strategies assess Stryker against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.